alexa Investigation of Pycnogenol(R) in combination with coenzymeQ10 in heart failure patients (NYHA II III).
Nursing

Nursing

Research & Reviews: Journal of Nursing and Health Sciences

Author(s): Belcaro G, Cesarone MR, Dugall M, Hosoi M, Ippolito E

Abstract Share this page

Aim. In this study we investigated benefits of a Pycnogenol –coenzyme Q10 combination (PycnoQ10) taken as an adjunct tomedical treatment in stable heart failure patients. The aim of this single-blinded,12-week observational study was to provi-de functional parameters such as exercise capacity,ejectionfraction and distal edema.

Methods. The essential element for inclusion was a stable level of heart failure within the past three months and stable NYHA classII or III (6 months). The heart failure management was in accor-dance with AHA guidelines for “best treatment.”The treatmentand control groups were comparable at baseline. The mean ageof the PycnoQ10-treated patients was 61.3±7.1 years and 62.1±3.7in the control group. All patients were taking medication andmost patients (>75%) used three or more drugs for heart failu-re treatment. There were two dropouts in the PycnoQ10 treatmentgroup and 6 in the control group (5 NYHA III patients).

Results. Nine PycnoQ10 treated patients (out of 32) and 3 (outof 21) taking placebo improved NYHA class. Systolic and dia-stolic pressure as well as heart rate and respiratory rate weresignificantly lowered with PycnoQ10 as compared to the con-trol group (P<0.05). No significant changes were observed incontrols. Heart ejection fraction increased by 22.4% in thetreatment group (P<0.05) versus 4.0% in controls. Walkingdistance on treadmill increased 3.3-fold in PycnoQ10 treatedpatients (P<0.05) but marginally improved in the control group.Distal edema decreased significantly in PycnoQ10 treatedpatients and only slightly in controls.

Conclusion. The association of Pycnogenol and CoQ10 may offeran important therapeutic option with a very good tolerability thatimproves heart failure management without side effects

  • To read the full article Visit
  • Open Access
This article was published in Panminerva Med and referenced in Research & Reviews: Journal of Nursing and Health Sciences

Relevant Expert PPTs

Relevant Speaker PPTs

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords